LMBA02 protocol for patients with a Burkitt lymphoma
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Methotrexate; Prednisolone; Vincristine
- Indications Burkitt's lymphoma
- Focus Therapeutic Use
- 13 Apr 2016 Results published in The Lancet.
- 10 Dec 2012 Primary endpoint 'Event-free-survival-rate' has been met.
- 10 Dec 2012 Results presented at the 54th Annual Meeting and Exposition of the American Society of Hematology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History